These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9368952

  • 1. Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A.
    Stokol T, Trepanier L, Parry BW, Finnin BC.
    Res Vet Sci; 1997; 63(1):23-7. PubMed ID: 9368952
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of fresh-frozen plasma and cryoprecipitate in dogs with von Willebrand's disease or hemophilia A.
    Stokol T, Parry B.
    J Vet Intern Med; 1998; 12(2):84-92. PubMed ID: 9560764
    [Abstract] [Full Text] [Related]

  • 3. The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A.
    Nichols TC, Bellinger DA, Reddick RL, Smith SV, Koch GG, Davis K, Sigman J, Brinkhous KM, Griggs TR, Read MS.
    Blood; 1993 May 15; 81(10):2644-51. PubMed ID: 8490173
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH, Kelley L, Green D.
    Am J Hematol; 1998 Aug 15; 58(4):311-8. PubMed ID: 9692396
    [Abstract] [Full Text] [Related]

  • 5. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
    Johnstone IB, Crane S.
    Can J Vet Res; 1987 Apr 15; 51(2):189-93. PubMed ID: 3111674
    [Abstract] [Full Text] [Related]

  • 6. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
    Michiels JJ, Berneman ZN, van der Planken M, Schroyens W, Budde U, van Vliet HH.
    Blood Coagul Fibrinolysis; 2004 Jun 15; 15(4):323-30. PubMed ID: 15166918
    [Abstract] [Full Text] [Related]

  • 7. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.
    Ching YN, Meyers KM, Brassard JA, Wardrop KJ.
    Am J Vet Res; 1994 Jan 15; 55(1):102-10. PubMed ID: 8141483
    [Abstract] [Full Text] [Related]

  • 8. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
    Cattaneo M, Simoni L, Gringeri A, Mannucci PM.
    Br J Haematol; 1994 Feb 15; 86(2):333-7. PubMed ID: 8199023
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of a collagen-binding activity assay as a screening test for type II von Willebrand disease in dogs.
    Sabino EP, Erb HN, Catalfamo JL.
    Am J Vet Res; 2006 Feb 15; 67(2):242-9. PubMed ID: 16454628
    [Abstract] [Full Text] [Related]

  • 14. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance.
    Terraube V, O'Donnell JS, Jenkins PV.
    Haemophilia; 2010 Jan 15; 16(1):3-13. PubMed ID: 19473409
    [Abstract] [Full Text] [Related]

  • 15. Comparison of albumin, colloid osmotic pressure, von Willebrand factor, and coagulation factors in canine cryopoor plasma, cryoprecipitate, and fresh frozen plasma.
    Culler CA, Iazbik C, Guillaumin J.
    J Vet Emerg Crit Care (San Antonio); 2017 Nov 15; 27(6):638-644. PubMed ID: 29064153
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups.
    Menache D, Aronson DL, Darr F, Montgomery RR, Gill JC, Kessler CM, Lusher JM, Phatak PD, Shapiro AD, Thompson AR, White GC.
    Br J Haematol; 1996 Sep 15; 94(4):740-5. PubMed ID: 8826903
    [Abstract] [Full Text] [Related]

  • 19. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G, Franchini M, Salvagno GL, Montagnana M, Poli G, Guidi GC.
    J Thromb Thrombolysis; 2008 Oct 15; 26(2):150-3. PubMed ID: 17786534
    [Abstract] [Full Text] [Related]

  • 20. Potential misdiagnosis of von Willebrand disease and haemophilia caused by ineffective mixing of thawed plasma.
    Favaloro EJ, Oliver S, Mohammed S, Ahuja M, Grzechnik E, Azimulla S, McDonald J, Lima-Oliveira G, Lippi G.
    Haemophilia; 2017 Sep 15; 23(5):e436-e443. PubMed ID: 28750474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.